These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 31087627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H, Guo X, Duan Y, Zheng B, Gao Y.
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.
    Tasani M, Ancliff P, Glover M.
    Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019
    [No Abstract] [Full Text] [Related]

  • 4. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, Recht M, Silverman RA, Tom WL, Pope E.
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [Abstract] [Full Text] [Related]

  • 5. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Wang Z, Li K, Dong K, Xiao X, Zheng S.
    Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
    [No Abstract] [Full Text] [Related]

  • 6. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V, Lopez-Gutierrez JC, Martinez R, Fernandez-Pineda I.
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X, Yang K, Chen S, Ji Y.
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y, Kong L, Sun B, Cui J, Shen W.
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [Abstract] [Full Text] [Related]

  • 10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J, Smink GM, Helm K, Xavier F.
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [Abstract] [Full Text] [Related]

  • 11. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W, Li K, Wang Z, Dong K, Zheng S.
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K.
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [Abstract] [Full Text] [Related]

  • 14. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E, Ametrano O, Diplomatico M, De Chiara C, Capasso M, Errico ME, Picciocchi R.
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract] [Full Text] [Related]

  • 15. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    MacFarland SP, Sullivan LM, States LJ, Bailey LC, Balamuth NJ, Womer RB, Olson TS.
    J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
    [Abstract] [Full Text] [Related]

  • 16. An intermediate vascular tumour between kaposiform hemangioendothelioma and tufted angioma with regression of the skin lesion.
    Makino T, Ishida W, Hamashima T, Mizawa M, Sasahara M, Shimizu T.
    Eur J Dermatol; 2017 Apr 01; 27(2):175-176. PubMed ID: 27882874
    [No Abstract] [Full Text] [Related]

  • 17. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S, Cassarino DS.
    JAMA Dermatol; 2013 Nov 01; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract] [Full Text] [Related]

  • 18. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
    Zhang G, Chen H, Gao Y, Liu Y, Wang J, Liu XY.
    Br J Dermatol; 2018 May 01; 178(5):1213-1214. PubMed ID: 29388191
    [No Abstract] [Full Text] [Related]

  • 19. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
    Wang Z, Li K, Dong K, Xiao X, Zheng S.
    J Pediatr Hematol Oncol; 2015 Jan 01; 37(1):72-3. PubMed ID: 24309604
    [No Abstract] [Full Text] [Related]

  • 20. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon.
    Das A, Bansal D, Chatterjee D, Das A.
    J Pediatr Hematol Oncol; 2017 Mar 01; 39(2):153-154. PubMed ID: 27820128
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.